Publications

Updated publication list October 2018

2018

  1. Bødker JS, Brøndum RF, Schmitz A, Schönherz AA, Jespersen DS, Sønderkær M, Vesteghem C, Due H, Nørgaard CH, Perez-Andres M, Samur MK, Davies F, Walker B, Pawlyn C, Kaiser M, Johnson D, Bertsch U, Broyl A, van Duin M, Shah R, Johansen P, Nørgaard MA, Samworth RJ, Sonneveld P, Goldschmidt H, Morgan GJ, Orfao A, Munshi N, Johnson HE, El-Galaly T, Dybkær K, Bøgsted M. A multiple myeloma classification system that associates normal B-cell subset phenotypes with prognosis. Blood Adv. 2018 Sep 25;2(18):2400-2411. doi:
    10.1182/bloodadvances.2018018564. PubMed PMID: 30254104; PubMed Central PMCID: PMC6156884.
  2. Tsukamoto S, Løvendorf MB, Park J, Salem KZ, Reagan MR, Manier S, Zavidij O, Rahmat M, Huynh D, Takagi S, Kawano Y, Kokubun K, Thrue CA, Nagano K, Petri A, Roccaro AM, Capelletti M, Baron R, Kauppinen S, Ghobrial IM. Inhibition of microRNA-138 enhances bone formation in multiple myeloma bone marrow niche. Leukemia. 2018 Jun 20. doi: 10.1038/s41375-018-0161-6. [Epub ahead of print] PubMed PMID: 29925904.
  3. Chery J, Petri A, Wagschal A, Lim SY, Cunningham J, Vasudevan S, Kauppinen S, Näär AM. Development of Locked Nucleic Acid Antisense Oligonucleotides Targeting Ebola Viral Proteins and Host Factor Niemann-Pick C1. Nucleic Acid Ther. 2018 Aug 22. doi: 10.1089/nat.2018.0722. [Epub ahead of print] PubMed PMID: 30133337.
  4. Wästerlid T, Biccler JL, Brown PN, Bøgsted M, Enblad G, Mészáros Jørgensen J, Christensen JH, Wahlin BE, Smedby KE, El-Galaly TC, Jerkeman M. Six cycles of R-CHOP-21 are not inferior to eight cycles for treatment of diffuse large B-cell lymphoma: a Nordic Lymphoma Group Population-based Study. Ann Oncol. 2018 Aug 1;29(8):1882-1883. doi: 10.1093/annonc/mdy184. PubMed PMID: 29790897.
  5. Melgaard D, Baandrup U, Bøgsted M, Bendtsen MD, Kristensen MT. Early mobilisation of patients with community-acquired pneumonia reduce length of hospitalisation-a pilot study. J Phys Ther Sci. 2018 Jul;30(7):926-932. doi: 10.1589/jpts.30.926. Epub 2018 Jul 3. PubMed PMID: 30034100
  6. El-Galaly TC, Villa D, Gormsen LC, Baech J, Lo A, Cheah CY. FDG-PET/CT in the management of lymphomas: Current status and future directions. J Intern Med. 2018 Jul 10. doi: 10.1111/joim.12813. [Epub ahead of print] Review. PubMed PMID: 29989234.
  7. Michaelsen TY, Richter J, Brøndum RF, Klapper W, Johnsen HE, Albertsen M, Dybkær K, Bøgsted M. A B-cell-associated gene signature classification of diffuse large B-cell lymphoma by NanoString technology. Blood Adv. 2018 Jul 10;2(13):1542-1546. doi: 10.1182/bloodadvances.2018017988. PubMed PMID: 29967255; PubMed Central PMCID: PMC6039667.
  8. Bech RS, Nielsen KL, Larsen TS, Bentzen HH, Lynggaard LS, Do TH, Braendstrup P, Brady J, Mikhaeel NG, Dybkaer K, Johnsen HE, Jensen P, Bøgsted M, El-Galaly TC. Real world data on rituximab maintenance therapy after frontline immunochemotherapy in grade 1-3a follicular lymphoma. Br J Haematol. 2017 May 23. doi: 10.1111/bjh.14775. [Epub ahead of print] PubMed PMID: 28542714.
  9. Chin CK, Tsang E, Mediwake H, Khair W, Biccler J, Hapgood G, Mollee P, Nizich Z, Joske D, Radeski D, Cull G, Villa D, El-Galaly TC, Cheah CY. Frequency of bowel perforation and impact of bowel rest in aggressive non-Hodgkin lymphoma with gastrointestinal involvement. Br J Haematol. 2018 Apr 20. doi: 10.1111/bjh.15173. [Epub ahead of print] PubMed PMID: 29676487.
  10. Wästerlid T, Biccler JL, Brown PN, Bøgsted M, Enblad G, Jørgensen JM, Christensen JH, Wahlin BE, Smedby KE, El-Galaly TC, Jerkeman M. Six cycles of R-CHOP-21 are not inferior to eight cycles for treatment of diffuse large B-cell lymphoma – A Nordic Lymphoma Group population-based study. Ann Oncol. 2018 May 22. doi: 10.1093/annonc/mdy184. [Epub ahead of print] PubMed PMID: 29790897.
  11. Thanarajasingam G, Minasian LM, Baron F, Cavalli F, De Claro RA, Dueck AC, El-Galaly TC, Everest N, Geissler J, Gisselbrecht C, Gribben J, Horowitz M, Ivy SP, Jacobson CA, Keating A, Kluetz PG, Krauss A, Kwong YL, Little RF, Mahon FX, Matasar MJ, Mateos MV, McCullough K, Miller RS, Mohty M, Moreau P, Morton LM, Nagai S, Rule S, Sloan J, Sonneveld P, Thompson CA, Tzogani K, van Leeuwen FE, Velikova G, Villa D, Wingard JR, Wintrich S, Seymour JF, Habermann TM. Beyond maximum grade: modernising the assessment and reporting of adverse events in haematological malignancies. Lancet Haematol. 2018 Jun 12. pii: S2352-3026(18)30051-6. doi: 10.1016/S2352-3026(18)30051-6. [Epub ahead of print]
    Review. PubMed PMID: 29907552.
  12. Juul MB, Jensen PH, Engberg H, Wehberg S, Dessau-Arp A, Haziri D, Kristensen HB, Baech J, Schurmann L, Clausen MR, Valentin R, Knudsen LM, Munksgaard L, El-Galaly TC, Frederiksen H, Larsen TS. Treatment strategies and outcomes in diffuse large B-cell lymphoma among 1011 patients aged 75 years or older: A Danish population-based cohort study. Eur J Cancer. 2018 Jun 20;99:86-96. doi: 10.1016/j.ejca.2018.05.006. [Epub ahead of print] PubMed PMID: 29935491.
  13. Wang X, Cao X, Sun R, Tang C, Tzankov A, Zhang J, Manyam GC, Xiao M, Miao Y, Jabbar K, Tan X, Pang Y, Visco C, Xie Y, Dybkaer K, Chiu A, Orazi A, Zu Y, Bhagat G, Richards KL, Hsi ED, Choi WWL, van Krieken JH, Huh J, Ponzoni M, Ferreri AJM, Møller MB, Parsons BM, Winter JN, Piris MA, Li S, Miranda RN, Medeiros LJ, Li Y, Xu-Monette ZY, Young KH. Clinical Significance of PTEN Deletion, Mutation, and Loss of PTEN Expression in De Novo Diffuse Large B-Cell Lymphoma. Neoplasia. 2018 Jun;20(6):574-593. doi: 10.1016/j.neo.2018.03.002. Epub 2018 May 4. PubMed PMID: 29734016; PubMed Central PMCID: PMC5994742.
  14. El-Galaly TC, Cheah CY, Bendtsen MD, Nowakowski GS, Kansara R, Savage KJ, Connors JM, Sehn LH, Goldschmidt N, Shaulov A, Farooq U, Link BK, Ferreri AJM, Calimeri T, Cecchetti C, Dann EJ, Thompson CA, Inbar T, Maurer MJ, Gade IL, Juul MB, Hansen JW, Holmberg S, Larsen TS, Cordua S, Mikhaeel NG, Hutchings M, Seymour JF, Clausen MR, Smith D, Opat S, Gilbertson M, Thanarajasingam G, Villa D. Treatment strategies, outcomes and prognostic factors in 291 patients with secondary CNS involvement by diffuse large B-cell lymphoma. Eur J Cancer. 2018 Apr;93:57-68. doi: 10.1016/j.ejca.2018.01.073. Epub 2018 Feb 21. PubMed PMID: 29477102; PubMed Central PMCID: PMC5869165.
  15. Andersen MA, Eriksen CT, Brieghel C, Biccler JL, da Cunha-Bang C, Helleberg M, Niemann CU. Incidence and predictors of infection among patients prior to treatment of chronic lymphocytic leukemia: a Danish nationwide cohort study. Haematologica. 2018 Mar 8. pii: haematol.2017.182006. doi: 10.3324/haematol.2017.182006. [Epub ahead of print] PubMed PMID: 29519862.
  16. Øvlisen AK, Oest A, Bendtsen MD, Bæch J, Johansen P, Lynggaard LS, Mølle I, Mortensen TB, Weber D, Ertner G, Schöllkopf C, Thomassen JQ, Nielsen OJ, Østgård LSG, Bøgsted M, Dybkær K, Johnsen HE, Severinsen MT. Stringent or nonstringent complete remission and prognosis in acute myeloid leukemia: a Danish population-based study. Blood Adv. 2018 Mar 13;2(5):559-564. doi: 10.1182/bloodadvances.2017007393. PubMed PMID: 29523528.
  17. Nørgaard CH, Jakobsen LH, Gentles AJ, Dybkær K, El-Galaly TC, Bødker JS, Schmitz A, Johansen P, Herold T, Spiekermann K, Brown JR, Klitgaard JL, Johnsen  HE, Bøgsted M. Subtype assignment of CLL based on B-cell subset associated gene signatures from normal bone marrow – A proof of concept study. PLoS One. 2018 Mar 7;13(3):e0193249. doi:  0.1371/journal.pone.0193249. eCollection 2018. PubMed PMID: 29513759.
  18. Biccler JL, Østgård LSG, Severinsen MT, Marcher CW, Møller P, Schöllkopf C, Friis LS, Bøgsted M, Jakobsen LH, El-Galaly TC, Nørgaard JM. Evolution of relative survival for acute promyelocytic leukemia patients alive at landmark time-points: a population-based study. Leukemia. 2018 Feb 23. doi: 10.1038/s41375-018-0054-8. [Epub ahead of print] PubMed PMID: 29476132.
  19. Biccler J, Eloranta S, de Nully Brown P, Frederiksen H, Jerkeman M, Smedby KE, Bøgsted M, El-Galaly TC. Simplicity at the cost of xanax accuracy in diffuse large B-cell lymphoma: a critical assessment of the R-IPI, IPI, and NCCN-IPI. Cancer Med. 2018 Jan;7(1):114-122. doi: 10.1002/cam4.1271. Epub 2017 Dec 13. PubMed PMID: 29239133; PubMed Central PMCID: PMC5773951.
  20. El-Galaly TC, Gormsen LC, Hutchings M. PET/CT for Staging; Past, Present, and Future. Semin Nucl Med. 2018 Jan;48(1):4-16. doi: 10.1053/j.semnuclmed.2017.09.001. Epub 2017 Sep 21. Review. PubMed PMID: 29195617.
  21. Poulsen LØ, Yilmaz MK, Oddershede L, Bøgsted M, Holt G, Eld M, Ljungmann K, Falkmer UG. Is the accuracy of preoperative MRI stage in rectal adenocarcinoma influenced by tumour height? Acta Oncol. 2018 Jan 31:1-7. doi: 10.1080/0284186X.2018.1433319. [Epub ahead of print] PubMed PMID: 29383974.
  22. Sørensen N, Jensen P, Clasen-Linde E, Larsen JM, El-Galaly T. Fatal cardiac arrhythmia caused by tumor lysis in a patient with diffuse large B-cell lymphoma upon start of R-CHOP. Clin Case Rep. 2018 Jan 26;6(3):490-493. doi: 10.1002/ccr3.1390. eCollection 2018 Mar. PubMed PMID: 29531724; PubMed Central PMCID: PMC5838273.
  23. Marcussen M, Sønderkær M, Bødker JS, Andersen M, Nielsen S, Vesteghem C, Christiansen I, Bergmann OJ, Bøgsted M, Dybkær K, Vyberg M, Johnsen HE. Oral mucosa tissue gene expression profiling before, during, and after radiation therapy for tonsil squamous cell carcinoma. PLoS One. 2018 Jan 16;13(1):e0190709. doi: 10.1371/journal.pone.0190709. eCollection 2018. PubMed PMID: 29338018.

 

PHD THESIS

Lasse Hjort Jacobsen 2018, “Analysis of relative survival patterns in cancer register data”

Mette Marcussen 2018, “Cancer Therapy Induced Mucositis, molecular characteristics influencing presence and severity of mucositis during cancer therapy”

 

Publications 2017

Publications 2016

Publications 2015

Publications 2014

Publications 2013

Publications 2012

Publications 2011

Publications 2010

Publications 2009 – 2004